Illumina, Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications i…
Medical - Diagnostics & Research
US, San Diego [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Illumina, Inc.'s gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2014 | 1.0000 | 1.820 | 1,421 | 1,550 | 125 | 281 | 374 | 481 | 254 | 413 | 381 | 304 |
| 2015 | 2.6100 | 3.235 | 1,861 | 2,212 | 353 | 421 | 372 | 690 | 443 | 560 | 466 | 501 |
| 2016 | 3.1800 | 3.243 | 2,219 | 2,396 | 461 | 512 | 633 | 723 | 623 | 588 | 524 | 767 |
| 2017 | 3.1500 | 3.676 | 2,398 | 2,728 | 462 | 580 | 571 | 824 | 579 | 670 | 583 | 874 |
| 2018 | 4.9700 | 5.595 | 2,752 | 3,328 | 726 | 884 | 606 | 1,005 | 606 | 817 | 674 | 1,066 |
| 2019 | 5.6200 | 6.278 | 3,333 | 3,530 | 826 | 847 | 883 | 1,159 | 883 | 806 | 794 | 703 |
| 2020 | 6.8200 | 4.280 | 3,543 | 3,188 | 1,002 | 521 | 985 | 912 | 985 | 462 | 835 | 776 |
| 2021 | 4.4600 | 5.560 | 3,239 | 4,451 | 656 | 878 | 580 | 1,344 | 580 | 1,093 | 941 | 1,426 |
| 2022 | 5.0800 | 2.228 | 4,526 | 4,572 | 762 | 554 | -123 | 948 | -123 | -195 | 2,092 | 1,594 |
| 2023 | -28.0500 | 0.727 | 4,584 | 4,464 | -4,404 | -3,044 | 4,887 | 1,043 | 354 | -214 | 1,297 | 1,754 |
| 2024 | -7.3500 | 3.970 | 4,504 | 4,349 | -1,161 | 627 | 362 | 1,313 | -70 | 1,068 | 1,490 | 1,393 |
| 2025 | - | 4.418 | - | 4,541 | - | 682 | - | 1,371 | - | 1,115 | - | 1,455 |
| 2026 | - | 5.196 | - | 4,855 | - | 2.F12X/td> | - | 2.F121/td> | - | 2.F121 | - | 2.F121 |
| 2027 | - | 6.038 | - | 5,173 | - | 1.F13X/td> | - | 1.F131/td> | - | 1.F131 | - | 1.F131 |
| 2028 | - | 6.718 | - | 5,442 | - | 0.F14X/td> | - | 0.F141/td> | - | 0.F141 | - | 0.F141 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
Equal-Weight
Prev. Grade
Equal-Weight
Nov. 22, 2024
Equal-Weight
Citigroup
1Y Ago:
Underweight
Prev. Grade
Overweight
Nov. 22, 2024
Equal-Weight
Overall Consensus
Grading Consensus
Click to each, to see the gradePrice Target Consensus
-15.534% $21.77 · MISS
Nov. 6, 2024Price Then
$154.96
Price Target
$161.91
Price Now
$140.14